Rite Aid Working Capital

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>RA</div>
RAD -- USA Stock  

 Earnings Call  In Two Weeks

Rite Aid working capital fundamental analysis lookup allows you to check this and other indicators for Rite Aid or any other equity instrument. You can also select from a set of available indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations. Please continue to Equity Screeners to view more equity screening tools

Search Working Capital

 
Refresh
Rite Aid Return on Invested Capital is expected to slightly increase based on the last few years of reporting. The last year's Return on Invested Capital was at 0.07.

Rite Aid Working Capital Analysis

Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
 2014 2016 2019 2020 (projected)
Interest Expense449.57 M397.61 M357.85 M363.38 M
Gross Profit7.83 B7.58 B6.82 B4.68 B
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.
Working Capital 
 = 
Current Assets 
Current Liabilities 
More About Working Capital | All Equity Analysis

Current Rite Aid Working Capital

1.55 B

Rite Aid Working Capital Over Time Pattern

 Rite Aid Working Capital 
      Timeline 

About Working Capital

Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
Compare to competition

Rite Aid Working Capital Related Assessment

  Capital Expenditure

Rite Aid has Working Capital of 1.55 B. This is 265.05% higher than that of the Healthcare sector, and significantly higher than that of Pharmaceutical Retailers industry, The Working Capital for all stocks is 5.12% lower than the firm.

Did you try this?

Run Idea Analyzer Now

   

Idea Analyzer

Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
All  Next Launch Module

Rite Aid Fundamentals

About Rite Aid Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Rite Aid's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Rite Aid using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Rite Aid based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way. Please read more on our fundamental analysis page.
 2010 2014 2019 2020 (projected)
Receivables949.06 M1.79 B1.29 B1.22 B
Inventories2.99 B1.87 B1.92 B2.57 B
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. Rite Aid Corporation was founded in 1962 and is headquartered in Camp Hill, Pennsylvania. Rite Aid operates under Pharmaceutical Retailers classification in USA and is traded on BATS Exchange. It employs 29840 people.


 
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page